Clinical trial Recruiting at 12 sites Observational Ages 18 and up

Evaluating the role of PET-CT in managing invasive fungal infections

Official title: A Prospective Multicenter Study to Determine the Usefulness of Systematic 18-FDG-PET-TC for the Management of Invasive Fungal Infection (PETIFI Project)

Run by Puerta de Hierro University Hospital · NCT05688592 · Data updated 2026-11-12

This study is testing if a special type of scan called PET-CT can help doctors better manage invasive fungal infections compared to regular imaging methods.

More Invasive Fungal Infections trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment224 (estimated)
SponsorPuerta de Hierro University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations14 sites (Majadahonda, Madriid and 13 other locations)
StatusRecruiting
StartedApril 27, 2023
Main results expectedOctober 31, 2024
Study endsDecember 1, 2024
Registry record updatedNovember 6, 2024
Trial IDNCT05688592 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with invasive fungal infections who can undergo a PET-CT scan.

Probably not a fit

Patients with active bacterial infections, recent surgeries in the affected area, or other medical conditions that may interfere with the study will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This national multicenter prospective cohort study aims to assess the added value of 18F-FDG PET-CT in the management of invasive fungal infections (IFI). It will compare the effectiveness of PET-CT against conventional radiological studies in terms of disease characterization, staging, and monitoring treatment response. Participants will undergo a PET-CT scan as part of their diagnostic work-up, and researchers will analyze how this imaging technique influences patient management and prognostic evaluations. The study will include patients with fungemia and focal IFIs, following established diagnostic criteria.

Why it matters

Potential benefit: If successful, this study could enhance the management and outcomes of patients with invasive fungal infections by providing more accurate diagnostic and prognostic information.

How similar studies have gone: While the use of PET-CT in fungal infections is not widely established, preliminary literature suggests that similar approaches may yield promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* 18-year-old adult patients
* who are admitted with a diagnosis of invasive fungal infection
* who able to undergo a one 18F-FDG PET-CT
* who give their informed consent.

Exclusion criteria:

* concomitant active bacterial infection likely to produce uptake in organs and tissues
* recent surgery in the area of the IFI (in the previous 3 months)
* other medical conditions that interfere with the development of the study ( e.g., inability to tolerate the performance of the test during the required time, pregnancy)
* terminal situation.

Where it's running

  • Hospital Universitario Puerta de Hierro
    Majadahonda, Madriid, Spain
    Recruiting
  • Hospital de Bellvitge
    Barcelona, Spain
    Recruiting
  • Hospital Universitario Clinic
    Barcelona, Spain
    Recruiting
  • Hospital Universitario Virgen de las Nieves
    Granada, Spain
    Recruiting
  • Hospital Infanta Leonor Hospital
    Madrid, Spain
    Recruiting
  • Hospital Universitario Gregorio Marañón
    Madrid, Spain
    Recruiting
Show 8 more locations
  • Hospital Universitario La Paz
    Madrid, Spain
    Recruiting
  • Hospital Unversitario Ramón y Cajal
    Madrid, Spain
    Recruiting
  • Hospital Virgen de la Victoria
    Málaga, Spain
    Recruiting
  • Hospital Universitario Central de Asturias
    Oviedo, Spain
    Recruiting
  • Hospital Unversitario de Salamanca
    Salamanca, Spain
    Recruiting
  • Hospital Universitario Virgenn de la Macarena
    Seville, Spain
    Recruiting
  • Hospital Morales Messeguer
    Murcia, Spain
    Not yet recruiting
  • Hospital Virgen de la Arrixaca
    Murcia, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: Ana Fernández Cruz, MDPhD — Hospital Puerta de Hierro-Majadahonda
  • Study coordinator: Andrea Gutiérrez Villanueva, MD
  • Email: a.gutierrezv@hotmail.com
  • Phone: +34618157518

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.